Cardinal Health, Inc. (CAH)

NYSE · Health Care · Medical Distribution
By Alex · Tickerpine
$237.92
+5.55 (+2.39%)
Price — last 10 years monthly, dividend-adjusted · hover for detail
Market Cap
$55.33B
P/E (TTM)
32.9
Forward P/E
16.9
EPS (TTM)
$7.23
ROE
Profit Margin
0.67%
Revenue Growth
5.80%
Dividend Yield
0.89%
Beta
0.52
52W High
$258.30
52W Low
$145.87
Analyst Target
$270.94

CAH stock forecast: what analysts expect

Consensus rating
Strong Buy
Avg. 12-month target
$270.94
Implied upside
+13.9%

Wall Street analysts covering Cardinal Health, Inc. currently rate the stock a Strong Buy on average, with a mean 12-month price target of $270.94 — +13.9% versus the last price of $237.92. Targets reflect analyst opinion, not a guarantee.

What would an investment in CAH be worth today?
Run CAH through our free historical return calculator.
Calculate CAH returns →

CAH historical returns

PeriodTotal returnAnnualized (CAGR)$1,000 grew to
1 year +61.6% +61.6% $1,616
3 years +185% +41.8% $2,854
5 years +405% +38.3% $5,054
10 years +295% +14.7% $3,945
20 years +676% +10.8% $7,757
Since 1985 +33,180% +15.0% $332,802

Based on monthly dividend-adjusted prices. See the full breakdown on what if you had invested in CAH.

CAH annual returns by year

2026 YTD +16.6%
2025 +76.3%
2024 +19.0%
2023 +34.1%
2022 +54.1%
2021 -0.4%
2020 +10.1%
2019 +18.0%
2018 -24.5%
2017 -12.6%

Congress trading in CAH

10 members of Congress have disclosed trading CAH — 10 purchases and 4 sales worth an estimated $346,000. Most recent disclosure: Apr 8, 2025.

See who in Congress traded CAH →

Insider activity in CAH

CAH's own executives and directors have made 0 open-market purchases ($0) and 31 sales ($59.6M) in the last 90 days, per SEC Form 4 filings. Most recent: Aug 19, 2026.

Aug 19, 2026Scherer Mary C. Chief Accounting Officer Sell $23,740
Aug 19, 2026Scherer Mary C. Chief Accounting Officer Sell $522,733
Aug 19, 2026Hollar Jason M. Chief Executive Officer Sell $1.4M
Aug 19, 2026Hollar Jason M. Chief Executive Officer Sell $809,941
Aug 19, 2026Hollar Jason M. Chief Executive Officer Sell $1.3M

About Cardinal Health, Inc.

Cardinal Health, Inc. operates as a healthcare services and products company in the United States and internationally. It operates in two segments: Pharmaceutical and Specialty Solutions, and Global Medical Products and Distribution. The company offers customized solutions for hospitals, healthcare systems, pharmacies, ambulatory surgery centers, clinical laboratories, physician offices, and patients in the home. It distributes branded and generic pharmaceutical, specialty pharmaceutical, and over-the-counter healthcare and consumer products. The company also provides services to pharmaceutical manufacturers and healthcare providers for specialty pharmaceutical products; pharmacy management services to hospitals; operates pharmacies, including pharmacies in community health centers; and repackages generic pharmaceuticals and over-the-counter healthcare products. In addition, it manufactures, sources, and distributes Cardinal Health branded medical, surgical, and laboratory products and devices that include exam and surgical gloves; needles, syringe, and sharps disposals; compression, incontinence, nutritional delivery, and wound care products; single-use surgical drapes, gowns, and apparel products; fluid suction and collection systems; urology products; operating room supply products; and electrode product lines. Further, the company distributes a range of national brand products, including medical, surgical, and laboratory products; provides supply chain services and solutions to hospitals, ambulatory surgery centers, clinical laboratories, and other healthcare providers; and assembles and sells sterile and non-sterile procedure kits. Additionally, it manufactures, prepares, and delivers radiopharmaceuticals; and optimizes direct shipments through integrated technology solutions. The company was incorporated in 1979 and is headquartered in Dublin, Ohio.

Company website ↗

CAH Key Statistics

Previous Close$232.37P/E Ratio32.9
Market Cap$55.33BPEG Ratio1.15
Revenue (TTM)$254.25BROE
Gross Margin3.84%ROA3.72%
Debt / EquityEmployees58,788

CAH in plain English

CAH stock: frequently asked questions

What is Cardinal Health, Inc.'s stock price today?

Cardinal Health, Inc. (CAH) last traded at $237.92 on the NYSE. Over the past 52 weeks the stock has traded between $145.87 and $258.30.

Is CAH stock a buy or a sell?

Wall Street analysts' consensus rating on CAH is "Strong Buy", with an average 12-month price target of $270.94 — about +13.9% versus the current price of $237.92. Analyst targets are opinions, not guarantees; always do your own research.

How much would $1,000 invested in CAH 10 years ago be worth today?

A $1,000 investment in Cardinal Health, Inc. made 10 years ago would be worth about $3,945 today (dividends reinvested) — a total return of 295%, or 14.7% per year.

Does CAH pay a dividend?

Yes. Cardinal Health, Inc. currently pays a dividend yielding about 0.89% per year at today's share price.

What is CAH's P/E ratio?

CAH trades at a trailing price-to-earnings ratio of 32.9, and 16.9 times expected forward earnings. The P/E ratio tells you how many dollars investors pay for each $1 of the company's annual profit.

Do members of Congress trade CAH stock?

Yes — 10 members of Congress have disclosed trades in CAH under the STOCK Act, totaling 10 purchases and 4 sales worth an estimated $346,000.

What is Cardinal Health, Inc.'s ticker symbol?

Cardinal Health, Inc. trades under the ticker symbol CAH on the NYSE.

Compare CAH with peers

CAH vs LLYEli Lilly and Company $1,233.66 CAH vs JNJJohnson & Johnson $273.14 CAH vs ABBVAbbVie Inc. $265.79 CAH vs MRKMerck & Co., Inc. $156.45 CAH vs UNHUnitedHealth Group Incorporated $396.59

Data last refreshed from public sources. Figures may be delayed. Not investment advice.